This Is Why with Dr. Busti

Sensitivity and specificity are some of the most misunderstood concepts in evidence-based medicine and diagnostic testing. In this episode of This Is Why with Dr. Busti, Dr. Busti breaks down the clinical meaning behind sensitivity, specificity, true positives, false positives, false negatives, and diagnostic accuracy using practical examples clinicians can immediately apply.

This Is Why understanding sensitivity and specificity matters far beyond memorization. Dr. Busti explains how clinicians use highly sensitive tests to rule out disease and highly specific tests to rule in disease while also demonstrating how false positives and false negatives influence patient care decisions.

You’ll also learn how to interpret 2x2 diagnostic tables, understand diagnostic accuracy, and apply concepts like SNOUT and SPIN correctly in clinical reasoning and evidence-based medicine.

Topics Covered:
- Sensitivity vs specificity explained
- True positives and false negatives
- True negatives and false positives
- Diagnostic accuracy basics
- Rule in vs rule out testing
- SNOUT and SPIN concepts
- Clinical interpretation of diagnostic tests
- 2x2 diagnostic tables explained
- False positive and false negative errors
- Applying diagnostic testing clinically

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/*** [ ADD GPT SLUG HERE ] ***

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#SensitivityAndSpecificity #DiagnosticTesting #EvidenceBasedMedicine #DiagnosticAccuracy #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Diagnostic tests used in research and clinical practice are essential to evidence-based medicine because they shape how clinicians diagnose disease, interpret tests, and make patient care decisions. In this episode of This Is Why with Dr. Busti, Dr. Busti explains how the precision and accuracy of diagnostic studies are designed, validated, and critically appraised using clinically relevant examples and practical reasoning.

This Is Why understanding sensitivity, specificity, predictive values, and likelihood ratios matters far beyond memorization. Dr. Busti walks through how clinicians determine whether a diagnostic test is useful, how bias affects study validity, and why gold-standard reference testing is critical in medical research.

Topics Covered:
- Diagnostic tests in clinical medicine
- Precision and accuracy of diagnostic tests explained
- Bias and error in diagnostic studies
- Considerations about the Gold Standard or Reference Tests

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#DiagnosticStudies #Diagnostictests #EvidenceBasedMedicine #EBM #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Diagnostic studies are foundational to evidence-based medicine because they help clinicians determine disease presence, severity, progression, and treatment response. In this episode of This Is Why with Dr. Busti, Dr. Busti explains the essential framework behind diagnostic studies, including sensitivity, specificity, predictive values, likelihood ratios, and critical appraisal tools used to evaluate study validity.

This Is Why understanding diagnostic studies matters for every clinician. Dr. Busti breaks down how diagnostic assays are developed, validated, and interpreted using practical clinical examples, including troponins, HIV viral load monitoring, BNP in heart failure, and lactate clearance in sepsis.

You’ll also learn how evidence-based medicine frameworks differ for diagnostic research, including PER, PIRT, and PIRO formats, along with the importance of gold standard reference tests, observer agreement, bias reduction, and diagnostic study reporting standards.

Topics Covered:
- Diagnostic studies in clinical medicine
- Sensitivity vs specificity explained
- Positive and negative predictive values
- Pre-test and post-test probability
- Likelihood ratios and diagnostic accuracy
- Gold standard reference testing
- Evidence-based medicine diagnostic frameworks
- Bias and validity in diagnostic studies
- QUADAS-2 critical appraisal overview
- Applying diagnostic evidence clinically

👉 High-Yield EBM Practice Questions: https://www.highyieldmedreviews.com/ebm-biostatistics-literature-evaluation-online-review-course

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#DiagnosticStudies #SensitivityAndSpecificity #EvidenceBasedMedicine #ClinicalReasoning #MedicalDiagnostics #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Regression analysis explained — understanding how variables influence outcomes is essential for interpreting clinical research in this episode of This Is Why with Dr. Busti.

Dr. Busti breaks down regression analysis and how it helps identify relationships between variables while controlling for confounders. This Is Why mastering regression allows you to determine whether an intervention truly drives outcomes—or if other factors are influencing the results.

You’ll learn the difference between linear and multivariate regression, how independent and dependent variables interact, and why controlling for confounders is critical for internal validity. Dr. Busti also connects regression analysis to the bigger picture of evidence-based medicine, helping you integrate statistical tools into real clinical decision-making.

Topics Covered:
- What regression analysis actually measures
- Independent vs dependent variables
- Linear regression and line of best fit
- Multivariate (multilinear) regression explained
- Logistic regression and outcome prediction
- Identifying and controlling confounders
- Reasons variables may not show significance
- Role of sample size and statistical power
- Internal vs external validity connection
- Applying regression to clinical research interpretation

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#regressionanalysis #confounders #biostatistics #clinicalresearch #Dr Busti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Tamsulosin for kidney stones is one of the most commonly prescribed therapies for ureteral stones — but does it actually help? In this episode of This Is Why with Dr. Busti, we break down the landmark SUSPEND trial and explain why the answer depends on the patient, the stone size, and the clinical context.

This Is Why many clinicians changed how they approach medical expulsive therapy after SUSPEND. But the real lesson is not simply whether to use tamsulosin — it’s understanding which patients are most likely to benefit and why later evidence refined the conversation.

Dr. Busti walks through the trial design, the limitations of pragmatic endpoints, subgroup nuance, and how later studies reshaped guideline recommendations for distal ureteral stones.

Topics Covered:
- Why the SUSPEND trial changed kidney stone management
- Medical expulsive therapy explained
- How tamsulosin works in ureteral stones
- Why stone size matters clinically
- Distal vs proximal ureteral stones
- Understanding the ceiling effect in clinical trials
- Why most stones ≤5 mm pass spontaneously
- Evidence for alpha blockers in larger stones
- CT-confirmed stone passage vs intervention outcomes
- How later trials refined the evidence
- Current EAU, NICE, and AUA guidance
- Which patients may benefit from tamsulosin
- Why nifedipine fell out of favor
- Applying evidence at the bedside
- Patient selection in evidence-based medicine

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tamsulosin-kidney-stones-suspend-trial

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
02:02 - Why the SUSPEND Trial Was Needed
04:00 - Study Design & Primary Outcome
07:09 - Trial Results
09:15 - Interpreting the Findings
11:02 - Later Evidence & Meta-Analyses
13:34 - Guidelines & Clinical Recommendations
15:52 - Bedside Application and Practice Takeaways
18:23 - Conclusion

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Tamsulosin #KidneyStones #MedicalExpulsiveTherapy #SUSPENDTrial #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Epistaxis explained by Dr. Busti. In this episode on This Is Why, we break down why epistaxis happens, how clinicians think through causes of bleeding, and why the location of bleeding matters clinically.

Dr. Busti explains anterior vs posterior epistaxis, common risk factors, medication-related bleeding, vascular anatomy, and when recurrent nosebleeds may signal a more serious underlying condition.

This episode connects anatomy, physiology, pathology, and clinical reasoning so healthcare professionals can better understand the “why” behind epistaxis and nosebleed management.

Topics Covered:
- What epistaxis means clinically
- Why nosebleeds happen
- Dryness and nasal mucosal irritation
- Trauma and nose picking
- Inflammation and upper respiratory infections
- Anticoagulants antiplatelets and NSAIDs
- Intranasal steroids and cocaine exposure
- Bleeding disorders and thrombocytopenia
- Hereditary hemorrhagic telangiectasia HHT
- Leukemia liver disease and vasculitis
- Kiesselbach plexus anatomy
- Anterior vs posterior epistaxis
- Why posterior bleeds are more concerning
- Risk factors for recurrent epistaxis
- Initial management principles for nosebleeds
- Why anatomy changes treatment decisions

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:11 - Pop Culture vs Clinical Reality
02:55 - Definition of Epistaxis
04:17 - Common Causes of Nosebleeds
07:42 - Medications & Bleeding Risk
09:00 - Systemic Diseases & Structural Causes
11:36 - Nasal Blood Supply & Kiesselbach's Plexus
13:11 - Anterior vs Posterior Epistaxis
15:04 - Treatment & Management of Epistaxis
16:21 - Conclusion

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#Epistaxis #Nosebleed #AnteriorEpistaxis #PosteriorEpistaxis #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Effect size (Relative risk vs odds ratio vs hazard ratio & NNT and NNH explained — This Is Why understanding these concepts is essential for interpreting clinical trials with Dr. Busti.

In this episode of This Is Why, Dr. Busti breaks down relative risk (RR), odds ratios (OR), absolute risk reduction (ARR), absolute risk increase (ARI), number needed to treat (NNT), and number needed to harm (MMH) in a way that connects directly to real clinical decision-making. This Is Why learning the “why” behind these calculations helps you move beyond memorization and actually apply evidence to patient care.

You’ll learn how to interpret whether a treatment increases or decreases risk, how to calculate and understand number needed to treat (NNT), and how to avoid common mistakes—like misinterpreting percentages or confusing statistical vs clinical meaning. Dr. Busti also walks through practical examples, including antihypertensive side effects, aspirin for MI prevention, and statin therapy, to show how these metrics influence real-world decisions.

Topics Covered:
- Definition of relative risk (risk ratio)
- When to use relative risk (RR) vs odds ratio (OR) vs hazards ratio (HR)
- Prospective vs retrospective study design
- Interpreting RR
- Confidence intervals and statistical significance
- Relative risk increase vs reduction
- Absolute risk reduction (ARR) explained
- Number needed to treat (NNT) & Number needed to harm (NNH) calculations
- Clinical vs statistical interpretation of risk
- Applying evidence to cost and patient outcomes

The goal = make medical education easy and clinically relevant.

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#relativerisk #oddsratio #nnt #ebm #Dr Busti 

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

D-dimer explained for DVT evaluation. This Is Why healthcare professionals must understand what an elevated D-dimer actually means before jumping to conclusions. Dr. Busti walks through a common deep vein thrombosis scenario and explains why compression ultrasonography—not automatic anticoagulation—is the correct next step when DVT is suspected.

Many learners incorrectly assume that an elevated D-dimer confirms a clot. Others memorize algorithms without understanding the clinical reasoning behind them. In this episode, Dr. Busti breaks down Wells score interpretation, pretest probability, D-dimer limitations, and how clinicians should approach suspected DVT in real-world practice.

Whether you're preparing for boards, rotations, residency, or clinical practice, this episode focuses on understanding the "why" behind thrombosis evaluation so you can confidently apply the "how."

Topics Covered:
- Understanding DVT pretest probability
- Interpreting the Wells-DVT score
- What D-dimer actually measures
- Why elevated D-dimer does not confirm DVT
- Negative predictive value and rule-out testing
- Age-adjusted versus conventional D-dimer thresholds
- When compression ultrasonography is indicated
- Why anticoagulation is not always the next step
- Common board exam traps in DVT evaluation
- Clinical reasoning for suspected venous thromboembolism

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/d-dimer-explained-suspected-dvt-ultrasound-exam-question

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#DVT #DDimer #WellsScore #DeepVeinThrombosis #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Stroke thrombolysis changed emergency neurology forever—but understanding why the NINDS trial mattered is what transforms memorization into clinical decision-making. In this episode of This Is Why with Dr. Busti, we break down the landmark NINDS rt-PA trial that established alteplase as a treatment for acute ischemic stroke and explore the real-world balance between functional recovery and intracerebral hemorrhage risk.

Dr. Busti explains how to interpret the trial beyond headlines by walking through the study design, inclusion criteria, outcomes, NNT and NNH calculations, odds ratios, bleeding risk, and the evolution of thrombolytic therapy from alteplase to tenecteplase. This episode also contextualizes modern AHA/ASA recommendations and what clinicians should actually say during bedside risk-benefit discussions with patients and families.

This Is Why medical education focuses on understanding the “why” behind clinical decisions so healthcare professionals can apply evidence with confidence and clarity.

Topics Covered:
- NINDS rt-PA trial explained
- Alteplase for acute ischemic stroke
- Stroke thrombolysis risks and benefits
- Functional recovery vs hemorrhage risk
- NNT and NNH interpretation
- Odds ratio vs absolute risk
- Tenecteplase vs alteplase
- Modern stroke thrombolysis guidelines
- Shared decision-making in stroke care
- Why early reperfusion matters

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/ninds-trial-stroke-thrombolysis-risks-benefits

🎥 Watch other videos referenced in this episode!
P-Value: https://youtu.be/ibl85Flpm94
Alpha Value Explained: https://youtu.be/Fmu4HwaGrtU
Power Analysis - Type II Error Risk: https://youtu.be/zn9q9E1IOoc

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:46 - NINDS Trial (1995)
04:40 - Trial Design, Inclusion & Exclusion Criteria
06:38 - Part 1: The Negative 24-Hour Endpoint Explained
11:28 - Part 2: Functional Outcomes That Changed Practice
13:45 - NNT, NNH & Explaining Risk to Patients
19:18 - One-Year Outcomes & Interpreting Odds Ratios Correctly
22:09 - Later Evidence, Meta-Analyses & Expanded Treatment Windows
25:30 - Tenecteplase vs Alteplase & Modern Stroke Practice
28:17 - Conclusion

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#AcuteIschemicStroke #NINDSTrial #StrokeThrombolysis #Alteplase #Tenecteplase #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Confidence intervals are one of the most misunderstood concepts in evidence-based medicine. In this episode of This Is Why with Dr. Busti, we break down what 95% confidence intervals actually mean, how they relate to p values and effect size, and why they are essential for interpreting clinical research correctly.

Dr. Busti walks through practical examples involving odds ratios, hazard ratios, relative risk, forest plots, and statistical significance so healthcare professionals can confidently evaluate published literature and apply evidence appropriately in clinical decision-making.

Whether you're preparing for boards, learning research interpretation, or improving your evidence-based medicine skills, this episode helps transform statistical confusion into clinical understanding.

Topics Covered:
- What a 95% confidence interval actually means
- Why confidence intervals matter in inferential statistics
- Relationship between confidence intervals and p values
- Understanding statistical significance
- Why confidence intervals can be wide or narrow
- Sample size and precision of results
- Interpreting odds ratios and hazard ratios
- Why crossing 1.0 matters for ratios
- Why crossing 0 matters for means
- Forest plot interpretation basics
- Clinical relevance versus statistical significance
- Confidence intervals in meta-analyses
- Understanding random error and confounding
- Examples from cardiovascular literature
- Evidence-based medicine interpretation strategies

This Is Why with Dr. Busti helps healthcare professionals move beyond memorization by understanding the why behind clinical evidence and patient care decisions.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/confidence-intervals-explained-medical-statistics

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

Chapter Table of Contents
00:00 - Introduction
01:52 - Concept Overview
03:29 - What a 95% Confidence Interval Really Means
04:39 - Why Narrow CI Matter
07:10 - Statistical Significance of CI
08:57 - Sample Question
12:01 - Integration & Application
12:56 - PROactive Trial & Aspirin Meta-Analysis
22:07 - Impact of Controlling for Confounders
24:01 - Conclusion

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#evidencebasedmedicine #confidenceinterval #statistics #clinicalresearch #medicaleducation #DrBusti

Speaker:
Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, is a licensed healthcare professional and medical educator with over 30 years of experience in clinical practice and academic teaching. He has trained and practiced as a nurse, pharmacist, and physician, bringing a uniquely comprehensive perspective to patient care and medical education.
Dr. Busti is dedicated to advancing evidence-based medicine and helping clinicians understand the underlying “why” behind clinical decisions to improve patient outcomes.

About This Channel:
This content is created by Anthony Busti, MD, PharmD, MSc, FAHA, FNLA, a board-certified physician with training at Johns Hopkins School of Medicine and University of Oxford and a medical educator for healthcare professionals and students. All material is based on current medical literature and evidence-based guidelines that align with principles of evidence-based medicine (EBM) and Evidence-Based Healthcare (EBHC).

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.